| Literature DB >> 28449648 |
Kerry Oxenford1, Rebecca Daley1, Celine Lewis2,3, Melissa Hill4,5, Lyn S Chitty1,2,3.
Abstract
BACKGROUND: The availability of non-invasive prenatal testing (NIPT) for aneuploidies is expanding rapidly throughout the world. Training health professionals to offer NIPT in a way that supports informed choice is essential for implementation. The aim of this study was to develop and evaluate a training package for health professionals to support the introduction of NIPT into clinical practice.Entities:
Keywords: Down syndrome; Education; Health professionals; Midwives; Non-invasive prenatal testing; Training
Mesh:
Year: 2017 PMID: 28449648 PMCID: PMC5408404 DOI: 10.1186/s12884-017-1315-7
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Participant demographics
| Pre/post training ( | Follow-up ( | Interviews ( | |
|---|---|---|---|
| Hospital and region (no. trained) | |||
| University College London Hospital, Central London (72) | 70 (18.4%) | 37 (24.5%) | 8 (22.9%) |
| Queens Hospital Romford, Essex (64) | 62 (16.3%) | 22 (14.6%) | 2 (5.7%) |
| St Georges Hospital, South West London (25) | 24 (6.3%) | 20 (13.2%) | 7 (20.0%) |
| Princess Alexandra Hospital, Hampshire (131) | 128 (33.6%) | 45 (29.8%) | 5 (14.3%) |
| Salisbury District Hospital, Wiltshire (20) | 18 (4.7%) | 7 (4.6%) | 4 (11.4%) |
| Tayside Hospital, Scotland (9) | 8 (2.1%) | 4 (2.6%) | 3 (8.6%) |
| Queen Charlottes and Chelsea Hospital, West London (38) | 38 (10.0%) | 8 (5.3%) | 4 (11.4%) |
| Whittington Hospital, North London (33) | 33 (8.7%) | 8 (5.3%) | 2 (5.7%) |
| Type of hospital | |||
| District General Hospital | 241 (63.3%) | 82 (54.3%) | 13 (37.1%) |
| Teaching Hospital | 140 (36.7%) | 69 (45.7%) | 22 (62.9%) |
| Age group in years | |||
| < 25 | 48 (13.1%) | 17 (11.6%) | 0 |
| 25 – 35 | 102 (27.8%) | 49 (33.6%) | 6 (20.0%) |
| 36 – 45 | 77 (21.0%) | 27 (18.5%) | 8 (26.7%) |
| 46 – 55 | 115 (31.4%) | 46 (31.5%) | 15 (50.0%) |
| > 56 | 24 (6.6%) | 7 (4.8%) | 1 (3.3%) |
| Gender | |||
| Female | 366 (97.3%) | 142 (96.6%) | 31 (88.6%) |
| Male | 10 (2.7%) | 5 (3.4%) | 4 (11.4%) |
| Profession | |||
| Midwife | 355 (96.2%) | 141 (96.6%) | 28 (82.4%) |
| Otherb | 14 (3.8%) | 5 (3.4%) | 6 (17.6%) |
| Which area do you currently work in? | |||
| Antenatal clinic | 38 (10.3%) | 14 (9.6%) | 4 (11.8%) |
| Fetal medicine | 25 (6.8%) | 18 (12.3%) | 2 (5.9%) |
| Community | 110 (29.8%) | 44 (20.1%) | 4 (11.8%) |
| Rotational midwifea | 15 (4.1%) | 6 (4.1%) | 0 |
| Delivery and birth centre | 8 (2.2%) | 4 (2.7%) | 0 |
| Antenatal screening midwife/coordinator | 3 (0.8%) | 3 (2.1%) | 5 (14.7%) |
| Postnatal ward | 3 (0.8%) | 2 (1.4%) | 0 |
| Student midwife | 22 (6.0%) | 8 (5.5%) | 0 |
| General inc. antenatal/community | 118 (32.0%) | 37 (24.3%) | 0 |
| Specialist midwife | 13 (3.5%) | 5 (3.4%) | 13 (38.2%) |
| Otherb | 14 (3.8%) | 5 (3.4%) | 6 (17.6%) |
| Length of time in post in years | |||
| < 1 | 32 (9.0%) | 18 (12.5%) | 9 (30.0%) |
| 2 – 5 | 201 (56.3%) | 83 (57.6%) | 13 (43.3%) |
| 6 – 10 | 64 (17.9%) | 23 (16.0%) | 6 (20.0%) |
| > 10 | 60 (16.8%) | 20 (13.9%) | 2 (6.7%) |
| Run booking clinics | |||
| Yes | 281 (75.7%) | 116 (78.4%) | 9 (25.7%) |
| No | 90 (24.3%) | 32 (21.6%) | 26 (74.3%) |
Missing data: between 2% and 6.3% of respondents did not answer one or more of the demographic questions
aMidwives who rotate between the maternity areas
bObstetricians, Genetics, Day Assessment Unit, Education, Ultrasound
Current practice in discussing Down syndrome screening at booking
| Information | Always | If asked | If I have time | Never |
|---|---|---|---|---|
| Genetic cause of Down syndrome | 107 (34.7%) | 158 (51.3%) | 8 (2.6%) | 35 (11.4%) |
| Common problems experienced by people with Down syndrome | 94 (31.1%) | 165 (54.6%) | 15 (5.0%) | 28 (9.3%) |
| What tests are available for Down syndrome | 298 (95.8%) | 12 (3.9%) | 1 (0.3%) | 0 |
| Down syndrome screening is an optional test | 290 (92.9%) | 22 (7.1%) | 0 | 0 |
| The accuracy of the Combined Test | 204 (66.2%) | 79 (25.6%) | 6 (1.9%) | 19 (6.2%) |
| What the options are after a high risk screening result | 283 (90.1%) | 31 (9.9%) | 0 | 0 |
Missing data: between 17.6% – 20.7% of respondents did not answer one or more of the questions
Summary of scales included in the questionnaire to measure confidence and knowledge
| Measure | Description | Items | Reliabilitya | Range | Q1 Mdn (IQR) | Q3 Mdn (IQR) | Outcome |
|---|---|---|---|---|---|---|---|
| Self-perceived confidence scale | Clinical scenario given. Confidence felt in discussing features of NIPT. | 13 items, 4 point Likert scales | 0.95 | 0 – 39 | 7 (9) | 23 (3) | Statistically significant improvement in self-perceived confidence |
| Self-perceived knowledge scale | Self-perceived knowledge regarding features of NIPT | 6 items, 4 point Likert scales | 0.92 | 0 – 18 | 1 (3) | 8 (4) | Statistically significant improvement in self-perceived knowledge |
| Knowledge Test | Knowledge of cffDNA, features of NIPT, care pathway for NIPT | 8 items, True, false, unsure | 0.81 | 0 – 8 | 2 (4) | 6 (2) | Statistically significant improvement in knowledge test |
aReliability was assessed using Cronbach’s alpha for Likert scales and Kuder-Richardson 20 Formula for dichotomous questions
Knowledge test - respondents were asked to choose if each statement was true, false or if they were unsure
| Knowledge test statement | Correct answer | Pre-training results | 1-month follow-up after training results | ||
|---|---|---|---|---|---|
| Correct | Incorrect/unsure | Correct | Incorrect/unsure | ||
| Cell free fetal DNA originates from cells in the placenta | True | 37 (25.3%) | 109 (74.7%) | 88 (63.8%) | 50 (36.2%) |
| The concentration of cell free fetal DNA decreases with gestation | False | 23 (15.6%) | 124 (84.4%) | 88 (42%) | 80 (58%) |
| NIPT measures chromosome levels to identify elevated levels of chromosome 21, 18 and 13 | True | 57 (38.5%) | 91 (61.5%) | 113 (81.9%) | 25 (18.1%) |
| NIPT for Down’s syndrome is over 99% accurate | True | 72 (48.6%) | 76 (51.4%) | 98 (71%) | 40 (29%) |
| The false positive rate for NIPT for Down’s syndrome is 10% | False | 28 (19%) | 119 (81%) | 88 (63.8%) | 50 (36.2%) |
| The turnaround time for the NIPT test is three weeks | False | 25 (16.9%) | 123 (83.1%) | 54 (39.4%) | 83 (60.6%) |
| NIPT for Down’s syndrome is being offered on a research basis to everyone with a screening test risk higher than 1:1000 | True | 52 (35.1%) | 96 (64.9%) | 109 (79%) | 29 (21%) |
| There are three possible NIPT results: positive, negative or inconclusive | True | 69 (46.6%) | 79 (53.4%) | 126 (91.3%) | 12 (8.7%) |
| Women who receive a positive NIPT result will be offered an invasive test to confirm the result | True | 65 (43.9%) | 83 (56.1%) | 129 (93.5%) | 9 (6.5%) |
Quotes from interview participants
| Quote number | Participant | Quote |
|---|---|---|
| 1 | HCP-CP33 |
|
| 2 | HCP-LG5 |
|
| 3 | HCP-KC2 | “ |
| 4 | HCP-JB9 | “ |
| 5 | HCP-HH35 |
|
| 6 | HCP-RM10 |
|
| 7 | HCP-MO12 |
|
| 8 | HCP-DT11 |
|